BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10720066)

  • 1. Expression of corticotropin-releasing hormone messenger ribonucleic acid in human pituitary corticotroph adenomas associated with proliferative potential.
    Xu B; Sano T; Yamada S; Li CC; Hirokawa M
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1220-5. PubMed ID: 10720066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
    Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urocortin expression in human pituitary gland and pituitary adenoma.
    Iino K; Sasano H; Oki Y; Andoh N; Shin RW; Kitamoto T; Totsune K; Takahashi K; Suzuki H; Nagura H; Yoshimi T
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3842-50. PubMed ID: 9360550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
    Alexander JM; Swearingen B; Tindall GT; Klibanski A
    J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro corticotropin-releasing hormone (CRH) stimulation of adrenocorticotropin release from corticotroph adenoma cells: effect of prolonged exposure to CRH and its interaction with cortisol.
    Grino M; Boudouresque F; Conte-Devolx B; Gunz G; Grisoli F; Oliver C; Jaquet P
    J Clin Endocrinol Metab; 1988 Apr; 66(4):770-5. PubMed ID: 2831247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of corticotropin-releasing hormone and dexamethasone on proopiomelanocortin messenger RNA level in human corticotroph adenoma cells in vitro.
    Suda T; Tozawa F; Yamada M; Ushiyama T; Tomori N; Sumitomo T; Nakagami Y; Demura H; Shizume K
    J Clin Invest; 1988 Jul; 82(1):110-4. PubMed ID: 2839542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human pituitary corticotroph adenomas in vitro: morphologic and functional responses to corticotropin-releasing hormone and cortisol.
    Horvath SE; Asa SL; Kovacs K; Adams LA; Singer W; Smyth HS
    Neuroendocrinology; 1990 Mar; 51(3):241-8. PubMed ID: 2157992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs.
    Vallette-Kasic S; Figarella-Branger D; Grino M; Pulichino AM; Dufour H; Grisoli F; Enjalbert A; Drouin J; Brue T
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3050-6. PubMed ID: 12843142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.
    Korbonits M; Chahal HS; Kaltsas G; Jordan S; Urmanova Y; Khalimova Z; Harris PE; Farrell WE; Claret FX; Grossman AB
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2635-43. PubMed ID: 12050228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review.
    Sahli R; Christ ER; Seiler R; Kappeler A; Vajtai I
    Pathol Res Pract; 2006; 202(6):457-64. PubMed ID: 16497445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary specific transcription factor messenger ribonucleic expression in adenomatous and nontumorous human pituitary tissues.
    Lloyd RV; Jin L; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
    Lab Invest; 1993 Nov; 69(5):570-5. PubMed ID: 8246449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph.
    Asa SL; Bamberger AM; Cao B; Wong M; Parker KL; Ezzat S
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2165-70. PubMed ID: 8964846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas.
    Stefaneanu L; Kovacs K; Horvath E; Lloyd RV; Buchfelder M; Fahlbusch R; Smyth H
    J Clin Endocrinol Metab; 1994 Jan; 78(1):83-8. PubMed ID: 8288720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of corticotropin-releasing hormone receptors on human pituitary corticotroph adenomas and their correlation with endogenous glucocorticoids.
    Grino M; Guillaume V; Boudouresque F; Margioris AN; Grisoli F; Jaquet P; Oliver C; Conte-Devolx B
    J Clin Endocrinol Metab; 1988 Aug; 67(2):279-83. PubMed ID: 2839535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
    Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki-67 and minichromosome maintenance-7 (MCM7) expression in canine pituitary corticotroph adenomas.
    Ishino H; Hara Y; Takekoshi S; Teshima T; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2011 Nov; 41(4):207-13. PubMed ID: 21982272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.